Fundraising FoxAstellas Venture Management LLC — 2013 Investments
1 investments dated 2013 · listed companies and verified rows first · show all
Crescendo Biologicscrescendobiologics.comin𝕏Dec 2013
Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersQuan CapitalSofinnova PartnersEMBL VenturesFuture Planet CapitalAvlar BioVentures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.